 | Up a level |
Ishii, Kazunari; Yamada, Takahiro; Hanaoka, Kohei; Kaida, Hayato; Miyazaki, Koichi; Ueda, Masami; Hanada, Kazushi; Saigoh, Kazumasa; Sauerbeck, Julia; Rominger, Axel; Bartenstein, Peter; Kimura, Yuichi (2020). Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images. Annals of nuclear medicine, 34(11), pp. 856-863. Springer 10.1007/s12149-020-01513-3
Beyer, Leonie; Brendel, Matthias; Scheiwein, Franziska; Sauerbeck, Julia; Hosakawa, Chisa; Alberts, Ian; Shi, Kuangyu; Bartenstein, Peter; Ishii, Kazunari; Seibyl, John; Cumming, Paul; Rominger, Axel (2020). Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer's disease, 74(1), pp. 101-112. IOS Press 10.3233/JAD-190818
Kaida, Hayato; Azuma, Koichi; Kawahara, Akihiko; Sadashima, Eiji; Hattori, Satoshi; Takamori, Shinzo; Akiba, Jun; Fujimoto, Kiminori; Rominger, Axel; Murakami, Takamichi; Ishii, Kazunari; Ishibashi, Masatoshi (2018). The assessment of correlation and prognosis among <sup>18</sup>F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients. OncoTarget, 9(62), pp. 31971-31984. Impact Journals LLC 10.18632/oncotarget.25865
Brendel, Matthias; Sauerbeck, Julia; Greven, Sonja; Kotz, Sebastian; Scheiwein, Franziska; Blautzik, Janusch; Delker, Andreas; Pogarell, Oliver; Ishii, Kazunari; Bartenstein, Peter; Rominger, Axel Oliver (2018). Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer’s Disease Patients with Depressive Symptoms. Journal of Alzheimer's disease, 65(3), pp. 793-806. IOS Press 10.3233/JAD-170387
